Adenoidal Hypertrophy Clinical Trial
Official title:
Endoscopic Partial Adenoidectomy Versus Total Adenoidectomy Regarding Rate of Recurrence and Relief of Symptoms
Efficacy of partial adenoidectomy versus total adenoidectomy regarding rate of recurrence and relief of nasal obstruction.
Status | Recruiting |
Enrollment | 60 |
Est. completion date | June 1, 2024 |
Est. primary completion date | March 1, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 1 Year and older |
Eligibility | Inclusion Criteria: - .all patients with adenoid hypertrophy causing airway obstruction. Exclusion Criteria: - 1. Chlidren known to have cleft palate ,submucous cleft palate or other medical problems causing velopharyngeal insufficiency. - 2 . Systemic medical problems interfering with surgery. - 3 . Refusal of parents to participate. - 4. Craniofacial abnormalities. - 5. Down syndrome. |
Country | Name | City | State |
---|---|---|---|
Egypt | AssiutU | Assiut |
Lead Sponsor | Collaborator |
---|---|
Assiut University |
Egypt,
1. Jervis-Bardy, J.; Department of Otolaryngology, Arkansas Children's Hospital, cLittle Rock, AR, United States. Journal of Craniofacial SurgeryVolume 30, Issue 5, Pages E454 - E4602019.
1. Kummer AW, Lee L. Evaluation and treatment of resonance disorders. Language, Speech, and Hearing Services in Schools, 27:271-281
Saunders NC, Hartley BE, Sell D, Sommerlad B. Velopharyngeal insufficiency following adenoidectomy. Clin Otolaryngol Allied Sci. 2004 Dec;29(6):686-8. doi: 10.1111/j.1365-2273.2004.00870.x. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Efficacy of partial adenoidectomy versus total adenoidectomy regarding rate of recurrence and relief of nasal obstruction. | 1. Relief of nasal obstruction while preserving the function of velopharyngeal valve and assessment of the recurrence rate. | 1 to 2 years . | |
Primary | Incidence of recurrence using fibro-optic evaluation | Relief of nasal obstruction of posterior nasal chona using fibro-optic evaluation and assessment of recurrence rate using also questionnaires sheets to all parents. | 1 to 2 years . |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04256590 -
Tongue Depressor-related Tongue Swelling
|
||
Completed |
NCT02559440 -
Mometasone Furoate and Oxymetazoline in the Treatment of Adenoid Hypertrophy
|
Phase 4 |